Donald Shapiro, MD, MPH in Jenkintown, PA - Otolaryngology

Donald Shapiro, MD, MPH is a Otolaryngology physician based in Jenkintown, Pennsylvania. Donald Shapiro is licensed to practice in Pennsylvania (license number MD032239E) and his current practice location is 1753 Harbison Way, Jenkintown, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (561) 420-5795.

NPI number for Donald Shapiro is 1881858371 and his current mailing address is 570 Ocean Dr, 301, Juno Beach, Florida. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1881858371.

Contact Information

	Donald Shapiro, MD, MPH
	1753 Harbison Way, Jenkintown, PA 19046-1568
	(561) 420-5795
	Not Available

Physician's Profile

Full Name	Donald Shapiro
Gender	Male
Speciality	Otolaryngology
Location	1753 Harbison Way, Jenkintown, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1881858371
Provider Enumeration Date: 07/14/2008
Last Update Date: 01/05/2024

Medical Identifiers

Medical identifiers for Donald Shapiro such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881858371	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MD032239E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Donald Shapiro is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Donald Shapiro, MD, MPH 570 Ocean Dr, 301, Juno Beach, FL 33408-1952 Ph: () -	Donald Shapiro, MD, MPH 1753 Harbison Way, Jenkintown, PA 19046-1568 Ph: (561) 420-5795

News Archive

Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma

Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.

SciDev.Net examines usefulness of global health data for policymakers

"The Global Burden of Disease (GBD) Study 2010, launched last December, brought unparalleled access to analyses of health and mortality trends spanning two decades," but "hurdles remain in ensuring the accessibility and usefulness of data for policymakers in the global South," SciDev.Net reports.

Natural variation shows promise for increasing provitamin A in cassava roots

The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.

KCI to submit labeling for its products cleared by FDA for home use

Kinetic Concepts, Inc. today announced it is the first manufacturer to commit to submitting labeling for its products used in the home to the Food and Drug Administration as part of the agency's medical device Home Use Initiative. KCI will voluntarily submit labeling for its products cleared by FDA for home use for inclusion in the home use device labeling repository on the FDA's website.

Diabetics who live in low-income neighborhoods are up to 10 times more likely to lose toe, foot, leg

It's no secret that poverty is bad for your health. Now a new UCLA study demonstrates that California diabetics who live in low-income neighborhoods are up to 10 times more likely to lose a toe, foot or leg than patients residing in more affluent areas of the state.

Donald Shapiro, MD, MPH - Otolaryngology in Jenkintown, PA